Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Allergy and Clinical Immunology. in Practice|July 1, 2022
Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and BeyondSusan V Jennings, Celeste C Finnerty, Jessica S Hobart, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 20, 2022
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on MastocytosisJohannes Lübke, Juliana Schwaab, Deborah Christen, et al.
The Lancet. Haematology|November 3, 2019
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort studyWolfgang R Sperr, Michael Kundi, Ivan Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology|October 19, 2015
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical ImmunologyKarin Hartmann, Luis Escribano, Clive Grattan, et al.
Leukemia|November 20, 2019
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM RegistryHanneke C Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, et al.
Leukemia|September 21, 2021
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosisRoberta Zanotti, Massimiliano Bonifacio, Giuseppe Lucchini, et al.
Blood Advances|September 28, 2022
Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasmsJack Chovanec, Ilker Tunc, Jason Hughes, et al.
Blood Advances|April 9, 2024
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREMJohannes Lübke, Alicia Schmid, Deborah Christen, et al.
Allergy|April 23, 2024
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registryMarek Niedoszytko, Aleksandra Gorska, Knut Brockow, et al.
Theranostics|January 4, 2021
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosisHanneke C Kluin-Nelemans, Mohamad Jawhar, Andreas Reiter, et al.
Pageof 12